Neurocrine Bioscience buy Wells Fargo & Company
Start price
13.02.26
/
50%
€105.55
Target price
13.02.27
€147.44
Performance (%)
8.10%
Price
02.04.26
€114.10
Summary
This prediction is currently active. With a performance of 8.10%, the BUY prediction by Wells_Fargo___Compan for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.696% | -0.696% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat